We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Video Expert Opinion
Round Table Discussions
Sign in
Join now
story of the week
Published in Advanced Prostate Cancer and
1 other channel

Journal Scan / Research · September 28, 2020

Apalutamide and Overall Survival in Prostate Cancer

European Urology

 

Save Recommend
Share

Additional Info

Disclosure statements are available on the authors' profiles:

Emmanuel Antonarakis MD

Gautam Jayram MD

Oliver Sartor MD

European Urology
Apalutamide and Overall Survival in Prostate Cancer
Eur Urol 2020 Sep 06;[EPub Ahead of Print], MR Smith, F Saad, S Chowdhury, S Oudard, BA Hadaschik, JN Graff, D Olmos, PN Mainwaring, JY Lee, H Uemura, P De Porre, AA Smith, SD Brookman-May, S Li, K Zhang, B Rooney, A Lopez-Gitlitz, EJ Small

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated